Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Alvotech scores in AbbVie trade secrets case, but the Humira [...]
Alvotech scores in AbbVie trade secrets case, but the Humira [...]
Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for [...]
Biogen, mRNA players on Merck’s M&A radar as CEO still [...]
Buyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is [...]
Biohaven’s Nurtec, with dual migraine approvals, hits $136M in quarterly [...]
GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 [...]
Bayer pledges $464M to upgrade, build production facilities in contraceptives [...]
AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds [...]
Judge denies Pfizer’s request to run 2 programs to subsidize [...]
Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health [...]